XTRA:BAYNPharmaceuticals
Bayer (XTRA:BAYN) On Henry Ford Health Deal And The Fair Value Question
Bayer (XTRA:BAYN) has drawn fresh attention after partnering with Henry Ford Health to widen clinical trial access, using data and AI to refine trial design across cardiovascular, oncology, and women’s health programs.
See our latest analysis for Bayer.
Against this backdrop, Bayer’s share price has moved to €47.23, with a 90 day share price return of 28.97% and a 1 year total shareholder return of 63.58%. This points to strengthening momentum as investors weigh recent partnerships and bond...